Energy Manager
3 semanas hace
I believe the CEO stated that he felt that the device would be widely accepted. As far as accuracy, yes this is important, and I believe from the recent report that they continue to have it down to 10ng/ml, with strives to improve on that. I do not know how the accuracy will compare to it's competitors, but I believe Lifeloc will have the most versatile device, with capabilities to test for a complete panel of drugs of abuse.
I'm sure that Lifeloc has done their testing in-house to evaluate a lot of the variables that can affect the outcomes of the test results, or they would not be releasing a prototype for Beta testing. There's a lot of things that can affect electronic equipment, including temperature, humidity, human error, etc... Most of these variables are rigorously tested in the lab or an environmental chamber - where you can adjust temperature, humidity, etc, and compare results.
I would not expect immediate acceptance of the device, because there is almost always adjustments that need to be made. This is why Lifeloc states that they expect commercialization later in 2025. This could surprise us and be sooner, or could drag out longer. Also keep in mind, that according to Andy Lehman, the majority holder, who is in his 90's, may be willing to basically sell the company for the "right price." At Lifeloc's current Market Cap, it is ripe for a merger or acquisition from bigger players in the field.
There is a limited number of shareholders, from my memory, it's only about 33. These shareholders are most likely long-term investors, vs. short term traders, which, I believe will hold the share price somewhat consistent. Not saying there may be a few spikes up or down, but any spike down would be a buying opportunity in my opinion, and downward pressure would probably be short lived - such as the big volume spike down that we saw back in June, which is when Mr. Lehman probably acquired the bulk of his shares.
Energy Manager
3 semanas hace
I agree that there was not much in the report to draw any interest to the stock. My point about the Beta testing, is that I don't see anyway around keeping it quiet. I feel that Lifeloc has probably been in talks about testing their new oral fluid test with their long list of customers over the past months. This includes many state and local police forces throughout the US, and the world.
The purpose of the testing, is to use a third party, outside of the Lifeloc team, to utilize the equipment as they would in day to day operations, and give feedback on the equipment's performance, any flaws, areas that need improvement, etc... Most manufacturers do this before they start to gear up for production of the equipment, so they can make any adjustments to the product, before they begin mass production. It was stated in the report that they wanted to do this before they began "tooling," which is the production set-up for the final product. This allows for any changes, in any of the parts used in the manufacturing process, such as dimension changes in injected molded parts, etc. This saves time and money over the long run, and gives the customer a better product.
Let's use this scenario... The New Jersey State Police agree to test out the new SpinDx product. They are currently being trained by Lifeloc trainers, and will begin testing the general population in 2 to 3 weeks, during routine traffic stops. In order for them to perform the test, they will have to get the participants agreement to take the test, and be informed that it will not be used against them in any way on a legal basis, because it is currently only being tested out by the state police.
Now I'm almost certain, that the New Jersey State Police would have to inform the public in advance, that they are going to begin this testing, of a new oral fluid test for the detection of drugs during traffic stops, and that it would not be used in a court of law, and it is only being performed for informational purposes only. I also believe, that local media, News networks, etc., would also be reporting on this new, roadside test that is being administered throughout the State of New Jersey.
Again, this is just a random scenario that I conjured up, but it's my opinion that this could occur within the next 6 weeks.
pdicamillo1
3 semanas hace
I just didn't see enough to get current investors or potential new investors excited. Lifeloc has a history of not making any news announcements between November and March and I just feel like we were promised a bit more than just the same old - same old.
However one new bit of news is the fact that Spin DX can now detect fentanyl:
"SpinDx has been demonstrated in our laboratory to effectively detect for delta-9-THC, cocaine, fentanyl, amphetamine methamphetamine, morphine, MDMA, and benzodiazepines."
Without new buying interest, history shows us that we will just trend downward with little to no volume. I hope I'm wrong but we could really use some news from Lifeloc that is outside of the quarterly reports.
Energy Manager
3 semanas hace
Yes, a little frustrating. One positive is that they did re-iterate that Beta testing will begin this quarter. They didn't elaborate on this, but there is only 6 weeks remaining in the quarter. It appears that they have prototype units that are ready, or nearly ready for this testing. I would imagine that once the Beta testing commences, this would be public knowledge, due to that fact that it will most likely be law enforcement/police conducting the testing on the general public.
Energy Manager
1 mes hace
Lifeloc should be reporting earnings within the next 10 trading days. Hopefully we will get some better insight of Beta testing of their new device - has it begun yet, who is doing the testing, etc...
Looking back to when I was first introduced to Lifeloc, and when I made my first trades in LCTC stock back around late 2016. I was buying in the $4 to $7 price range as more of a day trader, than investor back then. With news of the collaboration with Sandia Labs, and early stage development of the "THC Breathalyzer," the stock ran up into the low to mid $20's in a very short time. This was merely on news of early stage development of the device.
Now that we have seen years of consolidation in the stock price, and the product is near commercialization vs. simply news of early development, as in 2016/2017 - coupled with the current market sentiment of small cap companies making 10x moves in a day, wouldn't it be prudent to assume that a share price greater than the mid $20's is not only obtainable, but warranted? The Market Cap of this company currently sits at just over $10 Million dollars, which is miniscule, and actually considered Micro Cap. With the potential of this new device to increase revenue over $100 Million dollars, I still feel a mid $40's share price is substantiated. In comparison to it's peers, it is now grossly undervalued, even though it is "Best of Breed" in my opinion.
pdicamillo1
2 meses hace
We know that Lifeloc will not be presenting the SpinDx device at the upcoming SAPAA event but I have to think that when the SpinDx is ready to go and it does garner some interest from attendees, buyers, police forces, municipalities, competitors, etc. that's when the fun begins. If it is presented to the right person or group, we could see some fireworks in the stock price. It only takes one or two potential investors who really love the technology to really move this thing.
How much better is it going to be when we know that Lifeloc will be actively presenting the SpinDx device at these conferences and expos. Let's hope it happens soon! How great would Monday have been if this weekends SAPAA conference had Lifeloc providing demonstrations of the SpinDx device to all those attendees.
pdicamillo1
2 meses hace
When I google search "Lifeloc technologies public stock float" the results show:
"As of September 4, 2024, Lifeloc Technologies Inc.'s (LCTC) public stock float was 139,260 shares.
A stock's float is the number of shares that are available for the public to buy and sell. It doesn't include restricted stock held by insiders, but if insiders sell their stock, it becomes part of the float."
Marketwatch.com also confirms that number:
https://www.marketwatch.com/investing/stock/lctc
There just cannot possibly be that many publicly traded shares left that are not being held by long term investors.
Using those float numbers, the entire public market available for non-insiders is valued at just $584,892.
I know I'm not selling anytime soon and I have to imagine those on this board are locked up also so my point is if we get some really market moving news and we don't hold it down with shares to sell, it could move up very quickly just like Energy Manager said. Ideally I would like to see us get up there to at least in-line with the Cannabix valuation before we start seeing the news releases from Lifeloc.
#LCTCNoSharesToSell
#LCTCLockedUp
pdicamillo1
2 meses hace
A quick review of the Cannabix (BLOZF) latest quarterly earnings report continues to show no sales, no revenue, no product, a quarterly loss of $1.25 million, more dilution to current shareholders, and an accumulated deficit of over $38 million. They are spending $14,000 each day to fund activities with no source of revenue and investors continue to value this company 4 times that of Lifeloc. It's time for Lifeloc to finally play some catch up.
Energy Manager
2 meses hace
It's probably pretty fair to say that we probably won't hear much about their new product until the next earnings release, which is still over a month away. This should coincide closely with the November election, which I can only see as being a positive for anything marijuana related, due to both candidates stance on legalization.
As I have stated before, it is very important to understand that legalization of cannabis, does not mean that it will be legal to drive an automobile while impaired by marijuana, alcohol, or any other drug of abuse, including OTC drugs. The timing of Lifeloc's new device, that will provide a quantitative measurement of THC in a subject, could not be more appropriate for the "New America" in which we now live, where more adults now use marijuana daily, than alcohol. I would say that Lifeloc has all of the bases covered, and this is setting up to be the "perfect storm..."
I can also say, with some confidence, that all of the recent insiders purchasing their company's stock, did not buy the stock because they feel the price will be going down in the near term. That simply would not make sense. It's my opinion, that a $40 per share price is not unreasonable, and could be obtained very quickly, due to the very tight share structure of Lifeloc's common stock.
Patience...
pdicamillo1
2 meses hace
Lots of gems in this years Letter to Shareholders:
https://lifeloc.com/pub/media/pdf/shareholderLetter2023.pdf
Our SpinDx™ technology platform or "Lab on a Disk", which we anticipate bringing to market in 2025, consists of a series of devices and tests that can be used at the roadside, in emergency rooms and in workplace testing to obtain a rapid and quantitative measure for a panel of drugs of abuse. The SpinDx reader is the base product, which we anticipate will ship with the ability to read disks for delta-9-THC detection from an oral fluid sample collected from a test subject. With firmware updates, we expect the SpinDx to be able to read future disk offerings for a broader array of drug panels. Firmware updates will be available to customers through a subscription model, with disks and sample collection kits as consumables, together producing a potentially significant recurring revenue stream.
We anticipate that both quantitative and pass/fail disks will be made available, which would make this offering the only rapid, quantitative saliva test for delta-9 THC available on the market. Following this we expect to release a system based on our LX9 breathalyzer to collect a sample for analysis from breath, which, coupled with the SpinDx reader, we expect to complete our marijuana breathalyzer system.
We have improved the detection sensitivity for delta-9-THC as well as the robustness of the device. Our first utility patent application was filed in early 2024 covering some of the improvements that we have made on the SpinDx technology. We are continuing to work on developing this system into an easily portable device that can be used for roadside testing, as well as other venues requiring fast response. We have committed additional personnel and new equipment resources to this effort, with the goal of placing beta test units in 2024 with validation partners who have already been identified. We anticipate full commercialization and revenue contribution to begin in 2025. Human trials have begun validating SpinDx detection of delta-9-THC at the detection limits of 10 ng/ml in real-world human samples. We intend to prioritize the acceleration of SpinDx even at the expense of short-term profitability, with research and development investments, including validation testing, expected to remain high in 2024.
Energy Manager
3 meses hace
Yes, could be some interest brewing from the shows, or the fact that both Presidential candidates are now pushing for legalization of marijuana in the US. President Trump is now all-in on the rescheduling, and legalization of marijuana, and will be voting to legalize marijuana in his home state of Florida. Statistics show that more people use marijuana daily than alcohol, and this number will only continue to grow as more and more states legalize it. The important thing to remember is that as marijuana becomes legal in more states across America, and in other countries - it will never be legal to drive while impaired by alcohol, or any drug, legal, illegal, or even over the counter drugs. This includes cannabis.
The timing of the Beta testing for Lifeloc's device could not be better positioned, as the marijuana sector builds momentum going into the November election. Hopefully this will coincide simultaneously, and we will see a growing interest in Lifeloc's common stock, as state or local police forces start testing the device in real life situations. Lifeloc has stated that they have Beta testing in place, and are looking to add more agencies to the list for additional testing - which is expected to begin this year.